| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8226834 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 6 Pages |
Abstract
Patients with potentially operable disease who underwent primary SABR had a median OS that exceeded 5 years. This finding supports ongoing randomized clinical trials comparing surgery and SABR in cases of operable stage I NSCLC.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Frank J. M.D., Ph.D., Naomi E. B.Sc., Cornelis J.A. M.D., Ph.D., Ben J. M.D., Ph.D., Marinus A. M.D., Ph.D., Egbert F. M.D., Ph.D., Suresh Ph.D., F.R.C.R., M.R.C.P.,